Squarepoint Ops LLC lifted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 298.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 508,175 shares of the medical instruments supplier's stock after acquiring an additional 380,565 shares during the quarter. Squarepoint Ops LLC owned 0.25% of DENTSPLY SIRONA worth $12,659,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in the business. LRI Investments LLC grew its position in DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier's stock worth $31,000 after purchasing an additional 564 shares during the period. Rothschild Investment LLC purchased a new position in DENTSPLY SIRONA during the second quarter valued at approximately $32,000. Central Pacific Bank Trust Division acquired a new position in DENTSPLY SIRONA in the first quarter valued at approximately $64,000. Mather Group LLC. acquired a new position in DENTSPLY SIRONA in the first quarter valued at approximately $72,000. Finally, AM Squared Ltd purchased a new stake in DENTSPLY SIRONA in the 2nd quarter worth approximately $90,000. Hedge funds and other institutional investors own 95.70% of the company's stock.
DENTSPLY SIRONA Price Performance
Shares of NASDAQ XRAY traded up $0.70 during midday trading on Friday, hitting $27.05. The stock had a trading volume of 2,027,562 shares, compared to its average volume of 3,057,677. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57. The stock has a 50 day simple moving average of $25.54 and a 200-day simple moving average of $27.65. The company has a market capitalization of $5.48 billion, a PE ratio of -61.48, a P/E/G ratio of 1.25 and a beta of 1.00. DENTSPLY SIRONA Inc. has a 1 year low of $23.58 and a 1 year high of $37.60.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts' consensus estimates of $0.50 by ($0.01). DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The firm had revenue of $984.00 million during the quarter, compared to analysts' expectations of $993.61 million. During the same quarter in the previous year, the business posted $0.51 EPS. The company's revenue for the quarter was down 4.3% on a year-over-year basis. On average, sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.99 EPS for the current fiscal year.
DENTSPLY SIRONA Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be issued a $0.16 dividend. The ex-dividend date is Friday, September 27th. This represents a $0.64 dividend on an annualized basis and a yield of 2.37%. DENTSPLY SIRONA's payout ratio is -145.45%.
Wall Street Analyst Weigh In
Several research firms recently issued reports on XRAY. Barrington Research reiterated an "outperform" rating and issued a $36.00 target price on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Evercore ISI lowered their target price on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an "outperform" rating on the stock in a research note on Tuesday, July 9th. Robert W. Baird cut their price target on DENTSPLY SIRONA from $33.00 to $31.00 and set a "neutral" rating for the company in a research note on Monday, July 22nd. Needham & Company LLC reaffirmed a "buy" rating and issued a $34.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Finally, Stifel Nicolaus dropped their price objective on DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating on the stock in a report on Thursday, July 18th. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, DENTSPLY SIRONA currently has an average rating of "Moderate Buy" and an average price target of $33.22.
Check Out Our Latest Research Report on XRAY
DENTSPLY SIRONA Company Profile
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Articles
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
